Perspective Therapeutics Inc (AMEX: CATX) kicked off on Tuesday, down -3.79% from the previous trading day, before settling in for the closing price of $11.09. Over the past 52 weeks, CATX has traded in a range of $2.20-$19.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 51.31%. With a float of $48.31 million, this company’s outstanding shares have now reached $67.43 million.
In an organization with 119 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 3.58%, operating margin of -642.65%, and the pretax margin is -621.47%.
Perspective Therapeutics Inc (CATX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Perspective Therapeutics Inc is 28.35%, while institutional ownership is 70.32%. The most recent insider transaction that took place on Sep 12 ’24, was worth 39,500. Before that another transaction happened on Jun 17 ’24, when Company’s Chief Financial Officer bought 1,800 for $9.81, making the entire transaction worth $17,667. This insider now owns 35,971 shares in total.
Perspective Therapeutics Inc (CATX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 51.31% per share during the next fiscal year.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Take a look at Perspective Therapeutics Inc’s (CATX) current performance indicators. Last quarter, stock had a quick ratio of 27.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 81.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -1.02 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.81 million. That was better than the volume of 0.68 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 5.56%. Additionally, its Average True Range was 0.73.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 29.92%, which indicates a significant increase from 6.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.21% in the past 14 days, which was lower than the 68.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.93, while its 200-day Moving Average is $12.81. However, in the short run, Perspective Therapeutics Inc’s stock first resistance to watch stands at $11.06. Second resistance stands at $11.44. The third major resistance level sits at $11.72. If the price goes on to break the first support level at $10.40, it is likely to go to the next support level at $10.12. The third support level lies at $9.74 if the price breaches the second support level.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
The company with the Market Capitalisation of 719.45 million has total of 67,428K Shares Outstanding. Its annual sales at the moment are 1,430 K in contrast with the sum of -46,510 K annual income. Company’s last quarter sales were recorded 530 K and last quarter income was -11,700 K.
